Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Ligresti

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|April 1, 2009
New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivoAntonella Brizzi, Vittorio Brizzi, Maria Grazia Cascio, et al.
Journal of Neuroinflammation|December 28, 2019
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activityStefania Petrosino, Aniello Schiano Moriello, Roberta Verde, et al.
Journal of Medicinal Chemistry|June 17, 2016
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease AgentsSerena Montanari, Laura Scalvini, Manuela Bartolini, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 3, 2026
Cannabinoid receptors orchestrate distinct anti-tumour pathways in gastric cancer via and beyond specialized pro-resolving mediatorsMattia Costanzo, Poulami Kumar, Chiara De Simone, et al.
Gastroenterology|September 2, 2003
Possible endocannabinoid control of colorectal cancer growthAlessia Ligresti, Tiziana Bisogno, Isabel Matias, et al.
Cancer Letters|December 3, 2021
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancerPaola Chiodelli, Daniela Coltrini, Marta Turati, et al.
Computers in Biology and Medicine|April 23, 2024
DeLA-DrugSelf: Empowering multi-objective de novo design through SELFIES molecular representationDomenico Alberga, Giuseppe Lamanna, Giovanni Graziano, et al.
European Journal of Medicinal Chemistry|October 23, 2012
Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptorsSerena Pasquini, Maria De Rosa, Alessia Ligresti, et al.
International Journal of Molecular Sciences|July 14, 2023
Motifs in Natural Products as Useful Scaffolds to Obtain Novel Benzo[<i>d</i>]imidazole-Based Cannabinoid Type 2 (CB2) Receptor AgonistsAnalia Young Hwa Cho, Hery Chung, Javier Romero-Parra, et al.
Journal of Medicinal Chemistry|May 14, 2009
Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonistsClementina Manera, Giuseppe Saccomanni, Barbara Adinolfi, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|April 1, 2009
New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivoAntonella Brizzi, Vittorio Brizzi, Maria Grazia Cascio, et al.
Journal of Neuroinflammation|December 28, 2019
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activityStefania Petrosino, Aniello Schiano Moriello, Roberta Verde, et al.
Journal of Medicinal Chemistry|June 17, 2016
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease AgentsSerena Montanari, Laura Scalvini, Manuela Bartolini, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 3, 2026
Cannabinoid receptors orchestrate distinct anti-tumour pathways in gastric cancer via and beyond specialized pro-resolving mediatorsMattia Costanzo, Poulami Kumar, Chiara De Simone, et al.
Gastroenterology|September 2, 2003
Possible endocannabinoid control of colorectal cancer growthAlessia Ligresti, Tiziana Bisogno, Isabel Matias, et al.
Cancer Letters|December 3, 2021
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancerPaola Chiodelli, Daniela Coltrini, Marta Turati, et al.
Computers in Biology and Medicine|April 23, 2024
DeLA-DrugSelf: Empowering multi-objective de novo design through SELFIES molecular representationDomenico Alberga, Giuseppe Lamanna, Giovanni Graziano, et al.
European Journal of Medicinal Chemistry|October 23, 2012
Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptorsSerena Pasquini, Maria De Rosa, Alessia Ligresti, et al.
International Journal of Molecular Sciences|July 14, 2023
Motifs in Natural Products as Useful Scaffolds to Obtain Novel Benzo[<i>d</i>]imidazole-Based Cannabinoid Type 2 (CB2) Receptor AgonistsAnalia Young Hwa Cho, Hery Chung, Javier Romero-Parra, et al.
Journal of Medicinal Chemistry|May 14, 2009
Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonistsClementina Manera, Giuseppe Saccomanni, Barbara Adinolfi, et al.
Pageof 12